GNWSF
$0.57
Stagezero Life Sciences
$.02
2.91%
GNWSF
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Thursday
Nov 12
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when GNWSF reports earnings?
Beat
Meet
Miss

Where is GNWSF's stock price going from here?
Up
Flat
Down
Stock chart of GNWSF
Analysts
Summary of analysts' recommendations for GNWSF
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
StageZero Life Sciences Ltd is dedicated to the early detection of cancer and multiple disease states through whole blood. The company's test consists of Aristotle(R), a multi-cancer panel for simultaneously screening for cancers from a single sample of blood. StageZero Life Sciences Ltd, formerly known as GeneNews Ltd., is based in TORONTO, ON.